Investigation Overview
Oct. 22, 2012 (Shareholders Foundation) -- An investigation on behalf of investors of ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) shares over potential securities laws violations by ISIS Pharmaceuticals, Inc. and certain of its directors and officers in connection certain financial statements was announced . The investigation by a law firm focuses on possible claims on behalf of purchas...
You must register (for free) or login to view the entire investigation.